R&D

Is Biopharma Investing Too Much In Cancer R&D?
Forbes
Tue, 04/24/18 - 09:20 am
R&D
cancer
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Forbes
Fri, 04/20/18 - 09:48 am
Biogen
Ionis Pharmaceuticals
drug development
R&D
Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way
Fierce Pharma
Tue, 04/10/18 - 10:23 pm
Pfizer
R&D
Prevnar 13
vaccines
After yet another PhIII Alzheimer’s failure, experts try to map a path out of the wrecking field
Endpoints
Tue, 04/10/18 - 11:19 am
FDA
Alzheimer's disease
R&D
NIH
biomarkers
UMinn wins $42 million biomedical research grant
Post Bulletin, MN
Sun, 04/8/18 - 12:13 pm
R&D
grants
University of Minnesota
devices
Tired of finishing in last place, Eli Lilly’s new R&D chief wants to shake things up
Endpoints
Mon, 04/2/18 - 12:12 pm
Eli Lilly
R&D
Dan Skovronsky
Mitsubishi and Hitachi to use AI to hasten drug R&D
Pharmaforum
Tue, 03/27/18 - 10:04 pm
artificial intelligence
R&D
Mitsubishi
Hitachi
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Fierce Biotech
Sat, 03/24/18 - 09:09 am
Genentech
antibiotic resistance
antibiotics
R&D
drug discovery
BamA enzyme
Regeneron, Alnylam partner to turn discovery into new drugs for NASH
Biopharma Dive
Thu, 03/22/18 - 10:26 pm
Regeneron
Alnylam
NASH
R&D
drug discovery
Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Drug Delivery Business News
Thu, 03/22/18 - 09:03 am
Novartis
Harvard
immunotherapy
drug delivery
R&D
immuno-oncology
GlaxoSmithKline prescribes commercial reboot for pharma division
Yahoo/Reuters
Wed, 03/21/18 - 11:02 am
GSK
restructuring
Luke Miels
R&D
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Fierce Biotech
Wed, 03/21/18 - 09:20 am
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease
An immunotherapy pill for psoriasis? Escalier gets $19M Series B to tackle R&D
Endpoints
Tue, 03/13/18 - 09:31 pm
immunotherapy
psoriasis
Escalier
R&D
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Endpoints
Tue, 03/13/18 - 10:13 am
Teva Pharmaceutical
CGRP blockers
R&D
drug development
Heptares Therapeutics
Sanofi about to sell know-how and R&D center to Evotec for €60m
GoinPharma
Sat, 03/10/18 - 09:21 am
Sanofi
R&D
Evotec
Pfizer calls it quits on CytomX deal as research comes to naught
Fierce Biotech
Thu, 03/8/18 - 11:49 pm
Pfizer
R&D
CytomX
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Endpoints
Wed, 03/7/18 - 11:58 am
R&D
Martin Shkreli
RE-0024
Retrophin
Cyprus
clinical trials
Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys
Endpoints
Tue, 03/6/18 - 09:38 am
HIV
Gilead Sciences
R&D
Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog the pack in microbiome R&D
Endpoints
Fri, 03/2/18 - 09:49 am
Takeda
Finch Therapeutics
microbiome
R&D
5 Ways Valeant Pharmaceutical Plans to Turn Things Around
Motley Fool
Thu, 03/1/18 - 11:28 am
Valeant Pharmaceuticals
earnings
Ortho Dermatologics
debt
operational efficiency
R&D

Pages